Stock listing
NASDAQ:ELDN Eledon Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Eledon Pharmaceuticals, Inc.
Follow Eledon Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ELDN
$2.77 USD -0.27 (-8.9%)
Close on Oct 30, 2026
- Day range
- $2.75 – $3.04 USDOct 30, 2026
- Volume
- 1.26M sharesOct 30, 2026
- Market cap
- $225.1M USDAt the close on Oct 30, 2026 · price × 81.26M shares outstanding
- 52-week range
- $1.35 – $4.60 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $2.74M USDMedian day 810,600 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ELDN · Home | $2.77 USD | -0.27 (-8.9%) | 1,264,247 | $3.009 | $3.04 | $2.745 | $3.04 | Close on Oct 30, 2026 |
| Frankfurt:2TK | €2.60 EUR | +0.68 (+35.4%) | — | €2.60 | €2.60 | €2.60 | €1.92 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ELDN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.77 | -0.27 | -8.9% | $3.009 | $3.04 | $2.745 | 1,264,247 | |
| $3.04 | +0.28 | +10.1% | $2.77 | $3.219 | $2.73 | 3,096,919 | |
| $2.76 | +0.35 | +14.5% | $2.40 | $2.81 | $2.372 | 2,075,572 | |
| $2.41 | +0.20 | +9.0% | $2.22 | $2.44 | $2.22 | 929,234 | |
| $2.21 | -0.09 | -3.9% | $2.36 | $2.37 | $2.20 | 653,396 | |
| $2.30 | 0.00 | 0.0% | $2.29 | $2.35 | $2.195 | 420,025 | |
| $2.30 | +0.04 | +1.8% | $2.26 | $2.32 | $2.225 | 526,699 | |
| $2.26 | +0.005 | +0.2% | $2.25 | $2.33 | $2.24 | 625,621 | |
| $2.255 | +0.095 | +4.4% | $2.16 | $2.33 | $2.14 | 740,338 | |
| $2.16 | +0.03 | +1.4% | $2.15 | $2.24 | $2.11 | 1,048,471 | |
| $2.13 | -0.14 | -6.2% | $2.27 | $2.419 | $2.13 | 801,400 | |
| $2.27 | +0.02 | +0.9% | $2.25 | $2.349 | $2.21 | 581,900 | |
| $2.25 | -0.09 | -3.8% | $2.31 | $2.36 | $2.22 | 987,300 | |
| $2.34 | -0.10 | -4.1% | $2.49 | $2.49 | $2.32 | 1,167,600 | |
| $2.44 | -0.04 | -1.6% | $2.50 | $2.58 | $2.425 | 440,500 | |
| $2.48 | +0.06 | +2.5% | $2.42 | $2.556 | $2.42 | 818,700 | |
| $2.42 | 0.00 | 0.0% | $2.40 | $2.44 | $2.36 | 834,500 | |
| $2.42 | -0.03 | -1.2% | $2.42 | $2.48 | $2.39 | 583,400 | |
| $2.45 | -0.05 | -2.0% | $2.53 | $2.56 | $2.42 | 828,000 | |
| $2.50 | +0.01 | +0.4% | $2.53 | $2.57 | $2.45 | 720,200 | |
| $2.49 | +0.055 | +2.3% | $2.48 | $2.55 | $2.42 | 967,200 | |
| $2.435 | -0.095 | -3.8% | $2.52 | $2.55 | $2.425 | 616,300 | |
| $2.53 | +0.03 | +1.2% | $2.53 | $2.62 | $2.50 | 717,400 | |
| $2.50 | -0.14 | -5.3% | $2.64 | $2.64 | $2.49 | 712,200 | |
| $2.64 | -0.01 | -0.4% | $2.65 | $2.66 | $2.53 | 714,500 | |
| $2.65 | -0.03 | -1.1% | $2.68 | $2.685 | $2.62 | 619,800 | |
| $2.68 | -0.04 | -1.5% | $2.72 | $2.771 | $2.60 | 1,029,600 | |
| $2.72 | -0.17 | -5.9% | $2.90 | $2.94 | $2.685 | 1,317,800 | |
| $2.89 | +0.20 | +7.4% | $2.75 | $3.09 | $2.68 | 2,087,100 | |
| $2.69 | +0.07 | +2.7% | $2.74 | $2.74 | $2.59 | 607,300 | |
| $2.62 | -0.03 | -1.1% | $2.67 | $2.68 | $2.57 | 827,900 | |
| $2.65 | -0.02 | -0.7% | $2.73 | $2.79 | $2.615 | 556,000 | |
| $2.67 | -0.04 | -1.5% | $2.71 | $2.724 | $2.64 | 737,500 | |
| $2.71 | -0.06 | -2.2% | $2.79 | $2.81 | $2.655 | 804,800 | |
| $2.77 | -0.01 | -0.4% | $2.88 | $2.88 | $2.75 | 519,600 | |
| $2.78 | 0.00 | 0.0% | $2.82 | $2.86 | $2.75 | 638,200 | |
| $2.78 | -0.04 | -1.4% | $2.78 | $2.805 | $2.75 | 744,500 | |
| $2.82 | -0.11 | -3.8% | $2.95 | $2.99 | $2.81 | 670,400 | |
| $2.93 | -0.09 | -3.0% | $3.02 | $3.03 | $2.91 | 1,020,600 | |
| $3.02 | +0.09 | +3.1% | $2.975 | $3.055 | $2.93 | 1,197,300 | |
| $2.93 | -0.06 | -2.0% | $3.07 | $3.10 | $2.92 | 1,146,400 | |
| $2.99 | -0.02 | -0.7% | $3.04 | $3.13 | $2.92 | 1,224,300 | |
| $3.01 | +0.03 | +1.0% | $2.93 | $3.03 | $2.885 | 1,297,900 | |
| $2.98 | -0.22 | -6.9% | $3.175 | $3.175 | $2.925 | 1,836,700 | |
| $3.20 | -0.12 | -3.6% | $3.29 | $3.32 | $3.17 | 1,014,900 | |
| $3.32 | -0.03 | -0.9% | $3.36 | $3.42 | $3.245 | 970,700 | |
| $3.35 | -0.12 | -3.5% | $3.47 | $3.503 | $3.335 | 816,000 | |
| $3.47 | +0.06 | +1.8% | $3.45 | $3.50 | $3.40 | 970,100 | |
| $3.41 | -0.04 | -1.2% | $3.43 | $3.43 | $3.265 | 1,142,400 | |
| $3.45 | -0.07 | -2.0% | $3.54 | $3.58 | $3.41 | 743,900 | |
| $3.52 | -0.03 | -0.8% | $3.53 | $3.594 | $3.42 | 576,800 | |
| $3.55 | -0.07 | -1.9% | $3.65 | $3.712 | $3.53 | 1,105,900 | |
| $3.62 | +0.04 | +1.1% | $3.55 | $3.676 | $3.54 | 612,900 | |
| $3.58 | +0.04 | +1.1% | $3.54 | $3.739 | $3.539 | 866,500 | |
| $3.54 | -0.16 | -4.3% | $3.60 | $3.705 | $3.495 | 1,341,600 | |
| $3.70 | -0.07 | -1.9% | $3.81 | $3.85 | $3.69 | 626,500 | |
| $3.77 | +0.02 | +0.5% | $3.75 | $3.805 | $3.688 | 796,100 | |
| $3.75 | +0.07 | +1.9% | $3.66 | $3.76 | $3.60 | 724,052 | |
| $3.68 | -0.01 | -0.3% | $3.68 | $3.88 | $3.61 | 1,024,480 | |
| $3.69 | +0.23 | +6.6% | $3.46 | $3.70 | $3.44 | 929,700 | |
| $3.46 | +0.02 | +0.6% | $3.44 | $3.515 | $3.40 | 655,000 | |
| $3.44 | -0.05 | -1.4% | $3.52 | $3.56 | $3.42 | 771,100 | |
| $3.49 | +0.06 | +1.7% | $3.44 | $3.53 | $3.43 | 805,200 | |
| $3.43 | +0.05 | +1.5% | $3.42 | $3.50 | $3.32 | 1,601,100 | |
| $3.38 | -0.03 | -0.9% | $3.41 | $3.491 | $3.255 | 642,200 | |
| $3.41 | +0.10 | +3.0% | $3.35 | $3.425 | $3.295 | 1,079,000 |
- Ticker
- NASDAQ:ELDN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 33 slides
Calls
Replays
Eledon Pharmaceuticals (NASDAQ:ELDN) Q1 2024 Earnings Call
Thu, May 09, 2024 · 4:30 PM ET
Watch TranscriptEledon Pharmaceuticals (NASDAQ:ELDN) Q1 2023 Earnings Call
Thu, May 11, 2023 · 4:30 PM ET
Watch TranscriptEledon Pharmaceuticals (NASDAQ:ELDN) Q4 2022 Earnings Call
Thu, Mar 30, 2023 · 4:30 PM ET
Watch Transcript
Latest news
Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting
Oct 26, 2026
Closed $2.21 (-3.9%) on Oct 26, 2026
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
Oct 5, 2026
Closed $2.45 (-2.0%) on Oct 6, 2026
Eledon Presents Updated Long-Term Phase 2 BESTOW Extension Study Results at the International Congress of The Transplantation Society
Sep 22, 2026
Closed $2.89 (+7.4%) on Sep 22, 2026
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
Sep 9, 2026
Closed $2.82 (-3.8%) on Sep 9, 2026
Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026
Sep 3, 2026
Closed $2.93 (-2.0%) on Sep 3, 2026
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 13, 2026
Closed $3.54 (-4.3%) on Aug 14, 2026
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Jun 22, 2026
Closed $3.81 (-2.8%) on Jun 22, 2026
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
Jun 8, 2026
Closed $3.58 (+5.0%) on Jun 8, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 33 slides · September 2026
Technical Presentation (November 2025)
Technical · 32 slides · Nov 7, 2025
Investor Day (July 2025)
Investor day · 114 slides · Jul 9, 2025
Technical Presentation (November 2023)
Technical · 15 slides · Nov 2, 2023
Eledon Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 96 in all · newest Oct 26, 2026 · oldest 2021
- Calls
- 10 calls with a replay · 10 with a transcript · latest May 9, 2024
- Decks
- 7 decks · latest September 2026
Where Eledon Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ELDN · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ELDN | BOATS | United States | USD |
| Lang & Schwarz:A2QL00 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QL00 | LS Exchange | Germany | EUR |
| Tradegate:2TK | Tradegate | Germany | EUR |
| Dusseldorf:2TK | Dusseldorf | Germany | EUR |
| Frankfurt:2TK | Frankfurt | Germany | EUR |
| Munich:2TK | Munich | Germany | EUR |
| Stuttgart:2TK | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Eledon Pharmaceuticals, Inc.